Spero Therapeutics

(NASDAQ) SPRO

Current Price$2.69

Market Cap$154.57M

Since IPO (2017)-77%

5 Year-81%

1 Year+268%

1 Month+15%

Spero Therapeutics Financials at a Glance

Market Cap

$154.57M

Revenue (TTM)

$60.38M

Net Income (TTM)

$8.57M

EPS (TTM)

$0.12

P/E Ratio

22.44

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Price

$2.69

Volume

6,640

Open

$2.70

Price

$2.69

Volume

6,640

Open

$2.70

Previous Close

$2.67

Daily Range

$2.67 - $2.71

52-Week Range

$0.57 - $3.22

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Price

$2.69

Volume

6,640

Open

$2.70

Previous Close

$2.67

Daily Range

$2.67 - $2.71

52-Week Range

$0.57 - $3.22

SPRO News

Why Spero Therapeutics Stock Is Up 15% Today

James BrumleyJul 1, 2021

Why Spero Therapeutics Shares Are Sliding Today

Keith SpeightsSep 11, 2020

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Spero Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Esther Rajavelu, MBA

Website

www.sperotherapeutics.com

Headquarters

Cambridge, MA 02139, US

SPRO Financials

Key Financial Metrics (TTM)

Gross Margin

77%

Operating Margin

-0%

Net Income Margin

14%

Return on Equity

16%

Return on Capital

-0%

Return on Assets

12%

Earnings Yield

4.46%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$154.57M

Shares Outstanding

57.89M

Volume

6.64K

Avg. Volume

377.00K

Financials (TTM)

Gross Profit

$59.62M

Operating Income

$24.00K

EBITDA

$24.00K

Operating Cash Flow

$12.62M

Capital Expenditure

$0.00

Free Cash Flow

$12.62M

Cash & ST Invst.

$40.27M

Total Debt

$2.90M

Spero Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$39.66M

+163.6%

Gross Profit

$39.66M

+149.8%

Gross Margin

100.00%

N/A

Market Cap

$154.57M

N/A

Market Cap/Employee

$4.83M

N/A

Employees

N/A

Net Income

$31.52M

+250.9%

EBITDA

$29.77M

+242.8%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$37.37M

-23.1%

Accounts Receivable

$25.39M

-51.6%

Inventory

$0.00

N/A

Long Term Debt

$939.00K

-63.2%

Short Term Debt

$1.96M

+12.0%

Return on Assets

12.44%

N/A

Return on Invested Capital

-0.04%

N/A

Free Cash Flow

$8.35M

+64.3%

Operating Cash Flow

$8.35M

+64.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ABOSAcumen Pharmaceuticals, Inc.

ABOSAcumen Pharmaceuticals, Inc.$2.50-0.99%

HURATuHURA Biosciences, Inc.

HURATuHURA Biosciences, Inc.$2.15-3.15%

CRBPCorbus Pharmaceuticals Holdings, Inc.

CRBPCorbus Pharmaceuticals Holdings, Inc.$9.79-2.88%

SEERSeer, Inc.

SEERSeer, Inc.$1.94-0.77%

CGTXCognition Therapeutics, Inc.

CGTXCognition Therapeutics, Inc.$1.28+0.39%

ACTUActuate Therapeutics Inc

ACTUActuate Therapeutics Inc$2.92+2.63%

MCRBSeres Therapeutics, Inc.

MCRBSeres Therapeutics, Inc.$7.03-3.96%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$83.67-0.02%

NOKNokia

NOKNokia$11.11+0.04%

POETPoet Technologies

POETPoet Technologies$7.86-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.20-0.01%

ERASErasca

ERASErasca$9.82-0.49%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$53.97+0.03%

PFEPfizer

PFEPfizer$26.43-0.01%

Questions About SPRO

What is the current price of Spero Therapeutics?

Spero Therapeutics is trading at $2.69 per share.

What is the 52-week range for Spero Therapeutics?

Over the past 52 weeks, Spero Therapeutics has traded between $0.57 and $3.22.

How much debt does Spero Therapeutics have?

As of the most recent reporting period, Spero Therapeutics reported total debt of $2.90M.

How much cash does Spero Therapeutics have on hand?

Spero Therapeutics reported $40.27M in cash and cash equivalents in its most recent financial results.

What is Spero Therapeutics’s dividend yield?

Spero Therapeutics does not currently have a dividend yield.

Spero Therapeutics

Spero Therapeutics Financials at a Glance

SPRO News

Why Spero Therapeutics Stock Is Up 15% Today

Why Spero Therapeutics Shares Are Sliding Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Spero Therapeutics

SPRO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Spero Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SPRO

What is the current price of Spero Therapeutics?

What is the 52-week range for Spero Therapeutics?

How much debt does Spero Therapeutics have?

How much cash does Spero Therapeutics have on hand?

What is Spero Therapeutics’s dividend yield?

Premium Investing Services